-Reuters
Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate
Aptorum Group Limited (NASDAQ:APM) announces further interim data from its ongoing Phase 1 trial for ALS-4 targeting Staphylococcus aureus. Specifically, two…